This inventor holds 1 USPTO granted patent. Top assignee: Antibioticos, S.a.u.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Encarnacion Mellado Duran: Innovator in Enzymatic Processes
Introduction
Encarnacion Mellado Duran is a notable inventor based in Leon, Spain. He has made significant contributions to the field of enzymatic processes, particularly in the preparation of cephalosporanic acid. His innovative work has led to the development of a unique enzymatic process that utilizes modified enzymes for enhanced efficiency.
Latest Patents
Encarnacion holds a patent for an "Enzymatic process for the preparation of cephalosporanic 7β-(4-Carboxybutanamide) acid by means of the modified enzyme D-aminoacid oxidase of Trigonopsis variabilis produced in Escherichia coli." This patent outlines a detailed process that includes isolating the DNA corresponding to the gene coding for the enzyme, removing introns, and transforming strains to cultivate the enzyme through affinity chromatography. This innovative approach showcases his expertise in biochemistry and genetic engineering.
Career Highlights
Encarnacion is currently employed at Antibioticos, S.A.U., where he continues to advance his research in enzymatic processes. His work has not only contributed to the scientific community but has also had practical applications in the pharmaceutical industry. His dedication to innovation is evident in his research and development efforts.
Collaborations
Encarnacion has collaborated with esteemed colleagues such as Jose Luis Garcia Lopez and Estrella Cortes Rubio. These collaborations have fostered a productive environment for research and innovation, allowing for the exchange of ideas and expertise.
Conclusion
Encarnacion Mellado Duran is a pioneering inventor whose work in enzymatic processes has made a significant impact in the field. His patent and ongoing research at Antibioticos, S.A.U. highlight his commitment to advancing science and technology. His contributions are invaluable to the development of new pharmaceutical processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile